Month: March 2025

Wave Life Sciences Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

Written by Customer Service on March 4, 2025. Posted in Earnings Releases And Operating Results.

Dosing underway in INLIGHT trial of WVE-007 in obesity with clinical data expected in 2H 2025; enrollment complete in first single dose cohort Multi-dosing ongoing in 200 mg cohort of RestorAATion-2 clinical trial of WVE-006 in AATD with data expected in 2025; second single dose cohort initiated at 400 mg On track to deliver FORWARD-53 48-week data in DMD and feedback from regulators in 1Q 2025 IND submission expected 2H 2025 for potentially registrational WVE-003 Phase 2/3 study in HD with caudate atrophy as a primary endpoint Cash and cash equivalents of $302.1 million as of December 31, 2024, with runway expected into 2027 Investor conference call and webcast at 8:30 a.m. ET today CAMBRIDGE, Mass., March 04, 2025 (GLOBE NEWSWIRE) — Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking...

Nayax Reports Fourth Quarter and Full Year 2024 Results

Written by Customer Service on March 4, 2025. Posted in Earnings Releases And Operating Results.

Full Year revenue of $314.0 million, recurring revenue growth of 47% YoY On a constant currency basis revenue of $315.2 million, a 34% increase Adjusted EBITDA of $35.5 million (1) and Free Cash Flow of $18 million (1) for the year 2025 Revenue guidance of $410 million – $425 million 2025 Adjusted EBITDA(1)(2) guidance of $65 million – $70 million HERZLIYA, Israel, March 04, 2025 (GLOBE NEWSWIRE) — Nayax Ltd. (Nasdaq: NYAX, TASE: NYAX), a global commerce payments and loyalty platform designed to help merchants scale their business, today announced its financial results for the fourth quarter and full year ended December 31, 2024. “We are pleased to report another year of strong growth and performance for Nayax as we achieved several key milestones including significant revenue growth and margin expansion, robust operating...

Evolution Petroleum Announces Acquisition of Non-Operated Oil and Natural Gas Assets in New Mexico, Texas, and Louisiana

Written by Customer Service on March 4, 2025. Posted in Mergers And Acquisitions.

Strategic Benefits of the Acquisition:Adds approximately 440 net BOEPD of stable, low-decline production. Enhances cash flow visibility with a balanced commodity mix. Strengthens Evolution’s long-term dividend sustainability. Offers low-risk development opportunities with potential for incremental production growth. ~2.8x estimated Adjusted EBITDA1 for the next 12 months (NTM)2, providing immediate accretion. $9.0 million purchase price vs. ~$15 million of Proved Developed PV-103.HOUSTON, March 04, 2025 (GLOBE NEWSWIRE) — Evolution Petroleum Corporation (NYSE American: EPM) (“Evolution” or the “Company”) today announced that it has entered into a definitive agreement to acquire non-operated oil and natural gas assets in New Mexico, Texas, and Louisiana (the “Acquisition”). The total purchase...

Passage Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Recent Business Highlights

Written by Customer Service on March 4, 2025. Posted in Earnings Releases And Operating Results.

Interim data from Dose 1 PBFT02 demonstrated durable, elevated CSF PGRN and early evidence of reduction in plasma NfL levels, a disease progression biomarker, as compared to published natural history Enrolled first FTD-GRN patient to be treated with Dose 2 PBFT02, 50% lower than Dose 1 Expect to report 12-month data from Dose 1 and interim safety and biomarker data from Dose 2 in 2H 2025; plan to seek regulatory feedback on FTD-GRN pivotal trial design in 1H 2026 Extended cash runway into 1Q 2027 PHILADELPHIA, March 04, 2025 (GLOBE NEWSWIRE) — Passage Bio, Inc. (Nasdaq: PASG), a clinical stage genetic medicines company focused on improving the lives of patients with neurodegenerative diseases, today reported financial results for the fourth quarter and year ended December 31, 2024, and provided recent business highlights. “We are...

Vireo Growth Inc. Announces Fourth Quarter and Full Year 2024 Results

Written by Customer Service on March 4, 2025. Posted in Earnings Releases And Operating Results.

– Company achieves record revenue, gross profit margin and operating income in fiscal year 2024 – – FY24 revenue of $99.4 million increased 15.4% year-over-year excluding discontinued operations – – Fourth quarter 2024 revenue of $25.0 million increased 3.5% year-over-year and was flat sequentially – – Company ended fiscal year 2024 with $91.6 million in cash after closing private placement in December – – Merger Transactions, recent equity raise, and growth catalysts position Company for transformational 2025 – MINNEAPOLIS, March 04, 2025 (GLOBE NEWSWIRE) — Vireo Growth Inc. (“Vireo” or the “Company”) (CSE: VREO; OTCQX: VREOF), today reported financial results for its fourth quarter and fiscal year ended December 31, 2024. Key financial results are presented below in summary form with supporting commentary...

Bear Creek Mining Announces Strategic Review, Appointment of Christian Milau as Strategic Advisor

Written by Customer Service on March 4, 2025. Posted in Public Companies.

VANCOUVER, British Columbia, March 04, 2025 (GLOBE NEWSWIRE) — Bear Creek Mining Corporation (TSXV: BCM) (OTCQX:BCEKF) (BVL: BCM) (“Bear Creek” or the “Company”) announces that its Board of Directors (the “Board”) has initiated a comprehensive and thorough strategic review process (the “Strategic Review”) to explore and evaluate, on an expeditious basis, the strategic and financial options available to the Company with the ultimate view of enhancing value. The Board has also established a special committee of independent directors (the “Special Committee”) to manage the process, with a goal to complete the Strategic Review on an expeditious basis. Mr. Milau will advise the Special Committee and Board as the Company carries out the Strategic Review. Strategic Review The strategic and financial options that may be considered under...

Bear Creek Mining Announces Brokered Private Placement, Appointment of Peter C. Mitchell and Ian Grundy as Directors, Debt Amendments and Credit Extension

Written by Customer Service on March 4, 2025. Posted in Public Companies.

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, March 04, 2025 (GLOBE NEWSWIRE) — Bear Creek Mining Corporation (TSXV: BCM) (BVL: BCM) (“Bear Creek” or the “Company”) announces that it has entered into an agreement with BMO Capital Markets to act as sole bookrunner, on behalf of a syndicate of underwriters (collectively, the “Underwriters”), on a bought deal basis, for a private placement of 64,445,000 common shares of the Company (each, a “Share”), at a price of C$0.225 per Share (the “Offering Price”) to raise aggregate gross proceeds of approximately C$14.5 million (the “Offering”). Pursuant to the Offering, the Company has granted the Underwriters an option to purchase an additional 9,666,750 Shares pursuant to the Offering for additional gross...

Beamr Issues Annual CEO Letter to Shareholders: Highlighting 2024 Achievements and 2025 Strategy – Capitalizing on Market Validation

Written by Customer Service on March 4, 2025. Posted in Public Companies.

In 2025, Beamr plans to leverage the strong market validation it has gained in numerous meetings with prospective customers across key target markets, as well as participation in major events with industry leaders Herzliya, Israel, March 04, 2025 (GLOBE NEWSWIRE) — Beamr Imaging Ltd. (NASDAQ: BMR), a leader in video optimization technology and solutions, today issued a Letter to Shareholders from Sharon Carmel, Chief Executive Officer. Dear Shareholders: As we look toward a promising and exciting year ahead, I am proud to reflect on Beamr’s achievements throughout 2024, including our financial results and strong cash position for 2024, our recent accomplishments so far in Q1 2025, and look forward to our plans for Q2 2025. We believe that during 2025, Beamr will capitalize on the significant validation it has created in 2024 and...

APAM Announces Jason Gottlieb as Chief Executive Officer and Eric Colson as Executive Chair

Written by Customer Service on March 4, 2025. Posted in Public Companies.

MILWAUKEE, March 04, 2025 (GLOBE NEWSWIRE) — Artisan Partners Asset Management Inc. (NYSE: APAM, the “Company”) announced today the appointment of Jason Gottlieb, current President of the Company, to succeed Eric Colson as Chief Executive Officer, and the appointment of Mr. Colson as Executive Chair of the Company, each effective following the Company’s 2025 annual meeting of stockholders on June 4, 2025. At that time, it is expected that Mr. Gottlieb will be elected to the Company’s Board of Directors, and Mr. Colson will become Chair of the Board, assuming the role from Stephanie DiMarco who will transition to Lead Independent Director. Mr. Gottlieb joined Artisan Partners in October 2016 as a Managing Director of Investment Operations. He was promoted to Chief Operating Officer of Investments and Executive Vice President in...

Neuronetics Reports Fourth Quarter and Full Year 2024 Financial and Operating Results

Written by Customer Service on March 4, 2025. Posted in Earnings Releases And Operating Results.

MALVERN, Pa., March 04, 2025 (GLOBE NEWSWIRE) — Neuronetics, Inc. (NASDAQ: STIM) (the “Company” or “Neuronetics”) a vertically integrated, commercial stage, medical technology and healthcare company with a strategic vision of transforming the lives of patients whenever and wherever they need help, with the leading neurohealth therapies in the world, today announced its financial and operating results for the fourth quarter and full year of 2024. Fourth Quarter 2024 HighlightsAcquired Greenbrook TMS on December 9, 2024 Received an incremental $10 million in funding from Perceptive Advisors Fourth quarter 2024 revenue of $22.5 million, a 11% increase as compared to the fourth quarter 2023 U.S. NeuroStar Advanced Therapy System revenue of $3.8 million in the quarter U.S. treatment session revenue of $12.9 million No Greenbrook...

Month: March 2025

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals